Lassa Fever in Post-Conflict Sierra Leone

PLoS Neglected Tropical Diseases

Volumn 8, Issue 3, 2014, Pages

  Shaffer, Jeffrey G ^a   Grant, Donald S ^b   Schieffelin, John S ^c   Boisen, Matt L ^c,d   Goba, Augustine ^b   Hartnett, Jessica N ^c   Levy, Danielle C ^c   Yenni, Rachael E ^c   Moses, Lina M ^a,c   Fullah, Mohammed ^b   Momoh, Mambo ^b   Fonnie, Mbalu ^b   Fonnie, Richard ^b   Kanneh, Lansana ^b   Koroma, Veronica J ^b   Kargbo, Kandeh ^b   Ottomassathien, Darin ^d   Muncy, Ivana J ^d   Jones, Abigail B ^d   Illick, Megan M ^e   Kulakosky, Peter C ^f   Haislip, Allyson M ^c   Bishop, Christopher M ^c   Elliot, Deborah H ^c   Brown, Bethany L ^d   Zhu, Hu ^g   Hastie, Kathryn M ^h   Andersen, Kristian G ^i,j   Gire, Stephen K ^i,j   Tabrizi, Shervin ^i,j   Tariyal, Ridhi ^j   Stremlau, Mathew ^i,j   Matschiner, Alex ^e   Sampey, Darryl B ^e   Spence, Jennifer S ^c   Cross, Robert W ^c,k   Geisbert, Joan B ^k   Folarin, Onikepe A ^l   Happi, Christian T ^l   Pitts, Kelly R ^d   Geske, F Jon ^d   Geisbert, Thomas W ^k   Saphire, Erica Ollmann ^g,h   Robinson, James E ^c   Wilson, Russell B ^f   Sabeti, Pardis C ^h,i,m   Henderson, Lee A ^f   Khan, S Humarr ^b   Bausch, Daniel G ^a   Branco, Luis M ^f,n   Garry, Robert F ^c,j,n   more..

^a TULANE UNIVERSITY   (United States)

^b Kenema Government Hospital   (Sierra Leone)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Division of Medicine   (United States)

^e BioFactura Inc   (United States)

^f Autoimmune Technologies LLC   (United States)

^g Vybion Inc   (United States)

^h SCRIPPS RESEARCH INSTITUTE   (United States)

ⁱ HARVARD UNIVERSITY   (United States)

^j BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^k University of Texas Medical Branch School of Medicine   (United States)

^l REDEEMER S UNIVERSITY   (Nigeria)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ Zalgen Labs   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBAVIRIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNOASSAY; INCIDENCE; INFANT; LASSA FEVER; LONGITUDINAL STUDY; PREDICTIVE VALUE; PREGNANCY; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEASONAL VARIATION; SIERRA LEONE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOASSAY; INCIDENCE; INFANT; LASSA FEVER; LASSA VIRUS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RIBAVIRIN; SEASONS; SIERRA LEONE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84897466483     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002748     Document Type: Article

References (36)

1. Richmond JK, Baglole DJ, (2003) Lassa fever: epidemiology, clinical features, and social consequences. Bmj 327: 1271-1275.
2. Bond N, Schieffelin JS, Moses LM, Bennett AJ, Bausch DG, (2012) A Historical Look at the First Reported Cases of Lassa Fever: IgG Antibodies 40 Years After Acute Infection. Am J Trop Med Hyg 88: 241-4.
3. Buckley SM, Casals J, (1970) Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg 19: 680-691.
4. Watts GM, (2013) Lily Lyman Pinneo. The Lancet 380: 1552.
5. Bausch DG, Demby AH, Coulibaly M, Kanu J, Goba A, et al. (2001) Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis 1: 269-281.
6. Fraser DW, Campbell CC, Monath TP, Goff PA, Gregg MB, (1974) Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg 23: 1131-1139.
7. Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, et al. (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 22: 773-779.
8. Safronetz D, Lopez JE, Sogoba N, Traore SF, Raffel SJ, et al. (2010) Detection of Lassa virus, Mali. Emerg Infect Dis 16: 1123-1126.
9. Demby AH, Inapogui A, Kargbo K, Koninga J, Kourouma K, et al. (2001) Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals. Vector Borne Zoonotic Dis 1: 283-297.
10. Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A, (1974) Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185: 263-265.
11. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, et al. (1995) Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Bmj 311: 857-859.
12. Knobloch J, McCormick JB, Webb PA, Dietrich M, Schumacher HH, et al. (1980) Clinical observations in 42 patients with Lassa fever. Tropenmed Parasitol 31: 389-398.
13. McCormick JB, Fisher-Hoch SP, (2002) Lassa fever. Curr Top Microbiol Immunol 262: 75-109.
14. Monath TP, Maher M, Casals J, Kissling RE, Cacciapuoti A, (1974) Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg 23: 1140-1149.
15. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, et al. (1987) Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 155: 456-464.
16. McCormick JB, King IJ, Webb PA, Johnson KM, O'Sullivan R, et al. (1987) A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155: 445-455.
17. Peters CJ, Liu CT, Anderson GW Jr, Morrill JC, Jahrling PB, (1989) Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis 11 Suppl 4: S743-749.
18. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, et al. (1986) Lassa fever. Effective therapy with ribavirin. N Engl J Med 314: 20-26.
19. Khan SH, Goba A, Chu M, Roth C, Healing T, et al. (2008) New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 78: 103-115.
20. Walker DH, McCormick JB, Johnson KM, Webb PA, Komba-Kono G, et al. (1982) Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol 107: 349-356.
21. Branco LM, Matschiner A, Fair JN, Goba A, Sampey DB, et al. (2008) Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virol J 5: 74.
22. Branco LM, Boisen ML, Andersen KG, Grove JN, Moses LM, et al. (2011) Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Virol J 8: 404.
23. Branco LM, Grove JN, Boisen ML, Shaffer JG, Goba A, et al. (2011) Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J 8: 478.
24. Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, et al. (2011) Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J 8: 314.
25. Olschlager S, Lelke M, Emmerich P, Panning M, Drosten C, et al. (2010) Improved detection of Lassa virus by reverse transcription-PCR targeting the 5′ region of S RNA. J Clin Microbiol 48: 2009-2013.
26. Allan R, (1998) The progression from endemic to epidemic Lassa fever in war-torn West Africa. Emerging Diseases 2.
27. Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, et al. (2000) Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 38: 2670-2677.
28. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES, (1987) A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155: 437-444.
29. Price ME, Fisher-Hoch SP, Craven RB, McCormick JB, (1988) A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Bmj 297: 584-587.
30. Niklasson BS, Jahrling PB, Peters CJ, (1984) Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J Clin Microbiol 20: 239-244.
31. Monath TP, (1975) Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ 52: 577-592.
32. McCormick JB, (1987) Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol 134: 69-78.
33. Webb PA, McCormick JB, King IJ, Bosman I, Johnson KM, et al. (1986) Lassa fever in children in Sierra Leone, West Africa. Trans R Soc Trop Med Hyg 80: 577-582.
34. Monson MH, Cole AK, Frame JD, Serwint JR, Alexander S, et al. (1987) Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg 36: 408-415.
35. Donnelly J, (2011) How did Sierra Leone provide free health care? Lancet 377: 1393-1396.
36. Snell NJ, (2001) Ribavirin-current status of a broad spectrum antiviral agent. Expert Opin Pharmacother 2: 1317-1324.